Cargando…

3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes

OBJECTIVES/SPECIFIC AIMS: Increased right atrial pressure is known to be a predictor of poor outcomes after LVAD implantation. Whether resolution of right heart congestion prior to LVAD implantation is associated with more favorable outcomes is not well understood. METHODS/STUDY POPULATION: We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, Gaurav, Sutaria, Nilay, Vest, Amanda, DeNofrio, David, Kawabori, Masashi, Couper, Gregory, Kiernan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812885/
http://dx.doi.org/10.1017/cts.2019.126
_version_ 1783462733455294464
author Gulati, Gaurav
Sutaria, Nilay
Vest, Amanda
DeNofrio, David
Kawabori, Masashi
Couper, Gregory
Kiernan, Michael
author_facet Gulati, Gaurav
Sutaria, Nilay
Vest, Amanda
DeNofrio, David
Kawabori, Masashi
Couper, Gregory
Kiernan, Michael
author_sort Gulati, Gaurav
collection PubMed
description OBJECTIVES/SPECIFIC AIMS: Increased right atrial pressure is known to be a predictor of poor outcomes after LVAD implantation. Whether resolution of right heart congestion prior to LVAD implantation is associated with more favorable outcomes is not well understood. METHODS/STUDY POPULATION: We analyzed LVAD recipients from our institution from 1/1/2015 to 2/28/2018. We excluded patients bridged to LVAD with ECMO support. Patients with admission right atrial pressure (RAPadmit) and implant RAP (RAPimplant) ≥ 14 mmHg were defined as having persistent congestion, while patients with RAPadmit ≥ 14 mmHg and RAPimplant < 14 mmHg were defined as having resolved congestion. Baseline characteristics between groups were compared using the Chi-square and unpaired t-tests. Time to death or RVAD was compared between groups using Cox proportional hazards models. RESULTS/ANTICIPATED RESULTS: Of 57 LVAD recipients with RAPadmit ≥ 14 mmHg, 14 (25%) had persistent congestion at the time of LVAD implantation. While there were no statistically significant differences between groups, patients with persistent congestion were more likely to be INTERMACS profile 1 (21.4% vs 9.5%), less likely to have a destination therapy device strategy (28.6% vs 34.9%), less likely to have moderate or severe right ventricular (RV) dysfunction (64.3% vs 83.7%), and had similar RAPadmit (20.4 mmHg vs 18.9 mmHg) compared to patients with resolved congestion. Median follow up was 307 days. Patients with persistent congestion had a higher frequency of death or RVAD implantation compared to those with resolved congestion (50% vs 14%, HR 3.75, 95% CI 1.25–11.25, p=0.02). DISCUSSION/SIGNIFICANCE OF IMPACT: Among patients with elevated RAP at admission, patients with persistently elevated RAP at the time of LVAD implantation had worse outcomes than patients who were able to be decongested prior to surgery. These data support optimization of RV filling pressures prior to LVAD surgery.
format Online
Article
Text
id pubmed-6812885
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-68128852019-10-28 3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes Gulati, Gaurav Sutaria, Nilay Vest, Amanda DeNofrio, David Kawabori, Masashi Couper, Gregory Kiernan, Michael J Clin Transl Sci Clinical Epidemiology/Clinical Trial OBJECTIVES/SPECIFIC AIMS: Increased right atrial pressure is known to be a predictor of poor outcomes after LVAD implantation. Whether resolution of right heart congestion prior to LVAD implantation is associated with more favorable outcomes is not well understood. METHODS/STUDY POPULATION: We analyzed LVAD recipients from our institution from 1/1/2015 to 2/28/2018. We excluded patients bridged to LVAD with ECMO support. Patients with admission right atrial pressure (RAPadmit) and implant RAP (RAPimplant) ≥ 14 mmHg were defined as having persistent congestion, while patients with RAPadmit ≥ 14 mmHg and RAPimplant < 14 mmHg were defined as having resolved congestion. Baseline characteristics between groups were compared using the Chi-square and unpaired t-tests. Time to death or RVAD was compared between groups using Cox proportional hazards models. RESULTS/ANTICIPATED RESULTS: Of 57 LVAD recipients with RAPadmit ≥ 14 mmHg, 14 (25%) had persistent congestion at the time of LVAD implantation. While there were no statistically significant differences between groups, patients with persistent congestion were more likely to be INTERMACS profile 1 (21.4% vs 9.5%), less likely to have a destination therapy device strategy (28.6% vs 34.9%), less likely to have moderate or severe right ventricular (RV) dysfunction (64.3% vs 83.7%), and had similar RAPadmit (20.4 mmHg vs 18.9 mmHg) compared to patients with resolved congestion. Median follow up was 307 days. Patients with persistent congestion had a higher frequency of death or RVAD implantation compared to those with resolved congestion (50% vs 14%, HR 3.75, 95% CI 1.25–11.25, p=0.02). DISCUSSION/SIGNIFICANCE OF IMPACT: Among patients with elevated RAP at admission, patients with persistently elevated RAP at the time of LVAD implantation had worse outcomes than patients who were able to be decongested prior to surgery. These data support optimization of RV filling pressures prior to LVAD surgery. Cambridge University Press 2019-03-27 /pmc/articles/PMC6812885/ http://dx.doi.org/10.1017/cts.2019.126 Text en © The Association for Clinical and Translational Science 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-ncnd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Clinical Epidemiology/Clinical Trial
Gulati, Gaurav
Sutaria, Nilay
Vest, Amanda
DeNofrio, David
Kawabori, Masashi
Couper, Gregory
Kiernan, Michael
3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes
title 3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes
title_full 3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes
title_fullStr 3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes
title_full_unstemmed 3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes
title_short 3154 Resolution of right atrial congestion before LVAD implantation is associated with improved outcomes
title_sort 3154 resolution of right atrial congestion before lvad implantation is associated with improved outcomes
topic Clinical Epidemiology/Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812885/
http://dx.doi.org/10.1017/cts.2019.126
work_keys_str_mv AT gulatigaurav 3154resolutionofrightatrialcongestionbeforelvadimplantationisassociatedwithimprovedoutcomes
AT sutarianilay 3154resolutionofrightatrialcongestionbeforelvadimplantationisassociatedwithimprovedoutcomes
AT vestamanda 3154resolutionofrightatrialcongestionbeforelvadimplantationisassociatedwithimprovedoutcomes
AT denofriodavid 3154resolutionofrightatrialcongestionbeforelvadimplantationisassociatedwithimprovedoutcomes
AT kawaborimasashi 3154resolutionofrightatrialcongestionbeforelvadimplantationisassociatedwithimprovedoutcomes
AT coupergregory 3154resolutionofrightatrialcongestionbeforelvadimplantationisassociatedwithimprovedoutcomes
AT kiernanmichael 3154resolutionofrightatrialcongestionbeforelvadimplantationisassociatedwithimprovedoutcomes